vs
Side-by-side financial comparison of Incyte (INCY) and Lineage, Inc. (LINE). Click either name above to swap in a different company.
Lineage, Inc. is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× Incyte). Incyte runs the higher net margin — 23.8% vs 0.4%, a 23.4% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs -0.2%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 0.3%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Norwegian Cruise Line Holdings (NCLH) is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange.
INCY vs LINE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.3B |
| Net Profit | $303.3M | $6.0M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 5.0% |
| Net Margin | 23.8% | 0.4% |
| Revenue YoY | 20.9% | -0.2% |
| Net Profit YoY | 91.7% | — |
| EPS (diluted) | $1.47 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.3B | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.1B | $1.3B | ||
| Q2 24 | $1.0B | $1.3B |
| Q1 26 | $303.3M | $6.0M | ||
| Q4 25 | $299.3M | — | ||
| Q3 25 | $424.2M | $-100.0M | ||
| Q2 25 | $405.0M | $-6.0M | ||
| Q1 25 | $158.2M | $0 | ||
| Q4 24 | $201.2M | $-71.0M | ||
| Q3 24 | $106.5M | $-485.0M | ||
| Q2 24 | $-444.6M | $-68.0M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | 32.3% | ||
| Q2 25 | 93.5% | 31.9% | ||
| Q1 25 | 93.0% | 32.2% | ||
| Q4 24 | 92.5% | 32.3% | ||
| Q3 24 | 92.4% | 32.8% | ||
| Q2 24 | 92.7% | 33.4% |
| Q1 26 | 23.7% | 5.0% | ||
| Q4 25 | 22.3% | — | ||
| Q3 25 | 32.5% | 2.5% | ||
| Q2 25 | 43.6% | 1.7% | ||
| Q1 25 | 19.5% | 4.3% | ||
| Q4 24 | 25.6% | -1.6% | ||
| Q3 24 | 12.8% | -38.6% | ||
| Q2 24 | -45.8% | 5.5% |
| Q1 26 | 23.8% | 0.4% | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 31.1% | -7.3% | ||
| Q2 25 | 33.3% | -0.4% | ||
| Q1 25 | 15.0% | — | ||
| Q4 24 | 17.1% | -5.3% | ||
| Q3 24 | 9.4% | -36.3% | ||
| Q2 24 | -42.6% | -5.1% |
| Q1 26 | $1.47 | $0.03 | ||
| Q4 25 | $1.46 | — | ||
| Q3 25 | $2.11 | $-0.44 | ||
| Q2 25 | $2.04 | $-0.03 | ||
| Q1 25 | $0.80 | $0.01 | ||
| Q4 24 | $0.90 | $-0.52 | ||
| Q3 24 | $0.54 | $-2.44 | ||
| Q2 24 | $-2.04 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $8.2B |
| Total Assets | $7.3B | $19.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | $173.0M | ||
| Q3 24 | $1.3B | $409.0M | ||
| Q2 24 | $987.3M | $73.0M |
| Q1 26 | $5.6B | $8.2B | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $4.7B | $8.4B | ||
| Q2 25 | $4.2B | $8.6B | ||
| Q1 25 | $3.7B | $8.6B | ||
| Q4 24 | $3.4B | $8.6B | ||
| Q3 24 | $3.2B | $9.0B | ||
| Q2 24 | $3.0B | $4.9B |
| Q1 26 | $7.3B | $19.2B | ||
| Q4 25 | $7.0B | — | ||
| Q3 25 | $6.3B | $19.2B | ||
| Q2 25 | $5.8B | $19.4B | ||
| Q1 25 | $5.7B | $18.8B | ||
| Q4 24 | $5.4B | $18.7B | ||
| Q3 24 | $5.0B | $19.3B | ||
| Q2 24 | $4.7B | $18.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $943.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | 157.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $943.0M | ||
| Q4 25 | $543.3M | — | ||
| Q3 25 | $559.4M | $230.0M | ||
| Q2 25 | $44.7M | $258.0M | ||
| Q1 25 | $266.1M | $139.0M | ||
| Q4 24 | $381.2M | — | ||
| Q3 24 | $310.9M | $186.0M | ||
| Q2 24 | $-575.6M | $155.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $-12.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $-31.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 7.0% | ||
| Q1 25 | — | -0.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | -2.3% |
| Q1 26 | — | 4.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 11.5% | ||
| Q2 24 | — | 13.9% |
| Q1 26 | — | 157.17× | ||
| Q4 25 | 1.82× | — | ||
| Q3 25 | 1.32× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 1.89× | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
